Clinical study using human blood and PBMCs about IgG4-related disease.

Clinical study using human blood and PBMCs about IgG4-related disease. - Clinical study using human blood and PBMCs about IgG4-related disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012977

Enrollment

Registered

2014-01-31

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4-related disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: IgG4-related disease patients, control group patients (Castleman's disease, ANCA associated vasculitis , and Sj&ouml;gren's syndrome),and healthy volunteer,who consent to participate in the study in Hyogo College of Medicine and eleven research cooperation facilities

Exclusion criteria

Exclusion criteria: Not obtained the consent

Design outcomes

Primary

Measure	Time frame
Flow cytometry analysis(FACS),various stimulation test of PBMCs from each patients groups(IgG4-related disease patients ,healthy volunteer, Castleman's disease, ANCA associated vasculitis and Sj&ouml;gren's syndrome),and expression analysis of microRNA in the sample .	—

Countries

Japan

Contacts

Public ContactKen Ishii

National Institutes of Biomedical Innovation,Health and Nutrition Laboratory of Adjuvant Innovation

kenishii@biken.osaka-u.ac.jp072-641-8043

Outcome results